Rainer Ziermann

1.6k total citations
31 papers, 1.0k citations indexed

About

Rainer Ziermann is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Rainer Ziermann has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Virology and 12 papers in Hepatology. Recurrent topics in Rainer Ziermann's work include HIV Research and Treatment (13 papers), Hepatitis C virus research (12 papers) and HIV/AIDS drug development and treatment (11 papers). Rainer Ziermann is often cited by papers focused on HIV Research and Treatment (13 papers), Hepatitis C virus research (12 papers) and HIV/AIDS drug development and treatment (11 papers). Rainer Ziermann collaborates with scholars based in United States, Canada and Germany. Rainer Ziermann's co-authors include Mary C. Betlach, Richard Calendar, Christos J. Petropoulos, Neil Parkin, Chaitan Khosla, Robert A. Goldman, Leonard Katz, Sanjay Shah, Bryan Julien and Emilio A. Emini and has published in prestigious journals such as Nucleic Acids Research, Hepatology and Journal of Virology.

In The Last Decade

Rainer Ziermann

31 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer Ziermann United States 20 430 353 341 239 221 31 1.0k
Sebla B. Kutluay United States 21 504 1.2× 899 2.5× 860 2.5× 394 1.6× 37 0.2× 31 1.7k
Kevin Whitby United Kingdom 14 775 1.8× 521 1.5× 348 1.0× 529 2.2× 423 1.9× 20 1.7k
Carol Lackman-Smith United States 14 307 0.7× 330 0.9× 278 0.8× 149 0.6× 48 0.2× 22 791
Francesc Puig‐Basagoiti Spain 18 371 0.9× 206 0.6× 168 0.5× 277 1.2× 254 1.1× 22 1.1k
Lois B. Allen United States 19 408 0.9× 172 0.5× 399 1.2× 474 2.0× 47 0.2× 53 1.1k
Eric Ferrari United States 13 492 1.1× 169 0.5× 470 1.4× 581 2.4× 864 3.9× 17 1.4k
Luciana Jesus da Costa Brazil 17 326 0.8× 241 0.7× 146 0.4× 186 0.8× 84 0.4× 42 696
Simon P. Tucker United States 20 298 0.7× 207 0.6× 313 0.9× 414 1.7× 23 0.1× 34 1.0k
Atsuko Hachiya Japan 21 782 1.8× 810 2.3× 291 0.9× 234 1.0× 96 0.4× 58 1.1k
Musaddeq Hussain United States 14 151 0.4× 22 0.1× 619 1.8× 283 1.2× 279 1.3× 25 1.2k

Countries citing papers authored by Rainer Ziermann

Since Specialization
Citations

This map shows the geographic impact of Rainer Ziermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Ziermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Ziermann more than expected).

Fields of papers citing papers by Rainer Ziermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Ziermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Ziermann. The network helps show where Rainer Ziermann may publish in the future.

Co-authorship network of co-authors of Rainer Ziermann

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Ziermann. A scholar is included among the top collaborators of Rainer Ziermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Ziermann. Rainer Ziermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziermann, Rainer, et al.. (2010). Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system. Journal of Virological Methods. 165(2). 246–253. 12 indexed citations
2.
Ziermann, Rainer, et al.. (2008). PROCLEIX®West Nile virus assay based on transcription-mediated amplification. Expert Review of Molecular Diagnostics. 8(3). 239–245. 12 indexed citations
3.
Thaikruea, Lakkana, Satawat Thongsawat, Y L Fong, et al.. (2007). Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion. 47(10). 1803–1808. 27 indexed citations
4.
Agwale, Simon M., Clement Zeh, Ellen E. Paxinos, et al.. (2006). Genotypic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 in Antiretroviral Drug-Naive Nigerian Patients. AIDS Research and Human Retroviruses. 22(1). 22–26. 33 indexed citations
5.
Gómes, Perpétua, et al.. (2006). Comparison of the COBAS TAQMAN™ HIV-1 HPS with VERSANT HIV-1 RNA 3.0 Assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes. Journal of Virological Methods. 135(2). 223–228. 11 indexed citations
6.
Tsongalis, Gregory J., et al.. (2005). Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates. Journal of Clinical Virology. 34(4). 268–271. 5 indexed citations
7.
Friesenhahn, Michel, et al.. (2005). Comprehensive comparison of the VERSANT® HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR® 1.5 assays on 1000 clinical specimens. Journal of Clinical Virology. 34(4). 245–252. 21 indexed citations
8.
Israel‐Ballard, Kiersten, Rainer Ziermann, Christian M. Leutenegger, et al.. (2005). TaqMan RT-PCR and VERSANT® HIV-1 RNA 3.0 (bDNA) assay. Journal of Clinical Virology. 34(4). 253–256. 12 indexed citations
9.
Yao, Joseph D., Marcel Beld, Lynette Lin Ean Oon, et al.. (2004). Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 Assay. Journal of Clinical Microbiology. 42(2). 800–806. 41 indexed citations
10.
Agwale, Simon M., et al.. (2004). Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. Journal of Clinical Virology. 31. 3–6. 49 indexed citations
11.
12.
13.
Comanor, Lorraine, Mel Krajden, Kathryn E. Kronquist, et al.. (2002). Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. Journal of Clinical Virology. 28(1). 14–26. 19 indexed citations
14.
Brussel, Marianne Van, et al.. (2002). Identification of new type-specific patterns with the VERSANTTM HCV genotype kit (LIPA). Journal of Hepatology. 36. 239–239. 2 indexed citations
15.
Condra, Jon H., et al.. (2000). Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy. The Journal of Infectious Diseases. 182(3). 758–765. 116 indexed citations
16.
Julien, Bryan, Sanjay Shah, Rainer Ziermann, et al.. (2000). Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene. 249(1-2). 153–160. 125 indexed citations
17.
Ziermann, Rainer & Don Ganem. (1996). Homologous and Heterologous Complementation of HBV and WHV Capsid and Polymerase Functions in RNA Encapsidation. Virology. 219(2). 350–356. 20 indexed citations
18.
Linderoth, Nora A., Rainer Ziermann, Elisabeth Haggård‐Ljungquist, Gail E. Christie, & Richard Calendar. (1991). Nucleotide sequence of the DNA packaging and capsid synthesis geges of bacteriophage P2. Nucleic Acids Research. 19(25). 7207–7214. 22 indexed citations
19.
Ziermann, Rainer & Richard Calendar. (1990). Characterization of the cos sites of bacteriophages P2 and P4. Gene. 96(1). 9–15. 36 indexed citations
20.
Halling, C, Richard Calendar, Gail E. Christie, et al.. (1990). DNA sequence of satellite bacteriophage P4. Nucleic Acids Research. 18(6). 1649–1649. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebla B. Kutluay Breakdown of academic impact, for papers by Kevin Whitby Breakdown of academic impact, for papers by Carol Lackman-Smith Breakdown of academic impact, for papers by Francesc Puig‐Basagoiti Breakdown of academic impact, for papers by Lois B. Allen Breakdown of academic impact, for papers by Eric Ferrari Breakdown of academic impact, for papers by Luciana Jesus da Costa Breakdown of academic impact, for papers by Simon P. Tucker Breakdown of academic impact, for papers by Atsuko Hachiya Breakdown of academic impact, for papers by Musaddeq Hussain
Rankless by CCL
2026